Bialecka M - Search Results

1

Interleukin-10 gene polymorphism in Parkinson's disease patients.

Bialecka M, Klodowska-Duda G, Kurzawski M, Slawek J, Opala G, Bialecki P, Safranow K, Droździk M. Bialecka M, et al. Arch Med Res. 2007 Nov;38(8):858-63. doi: 10.1016/j.arcmed.2007.06.006. Epub 2007 Aug 3. Arch Med Res. 2007. PMID: 17923267

2

[Clinical role of the Fas/Fas ligand system].

Droździk M, Białecka M. Droździk M, et al. Among authors: bialecka m. Pol Arch Med Wewn. 1999 Apr;101(4):337-43. Pol Arch Med Wewn. 1999. PMID: 10740413 Review. Polish. No abstract available.

3

N-acetyltransferase 2 polymorphism in sporadic Parkinson's disease in a Polish population.

Bialecka M, Gawronska-Szklarz B, Drozdzik M, Honczarenko K, Stankiewicz J. Bialecka M, et al. Eur J Clin Pharmacol. 2002 Feb;57(12):857-62. doi: 10.1007/s00228-001-0415-4. Eur J Clin Pharmacol. 2002. PMID: 11936704

4

[Role of gene polymorphism of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), cytochrome P450 2D6 (CYP2D6) and N-acetyltransferase 2 (NAT2) in pathogenesis of Parkinson's disease].

Białecka M, Droździk M, Podraza H. Białecka M, et al. Neurol Neurochir Pol. 2002 Jan-Feb;36(1):113-21. Neurol Neurochir Pol. 2002. PMID: 12053603 Review. Polish.

5

Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.

Droździk M, Białecka M, Myśliwiec K, Honczarenko K, Stankiewicz J, Sych Z. Droździk M, et al. Among authors: bialecka m. Pharmacogenetics. 2003 May;13(5):259-63. doi: 10.1097/01.fpc.0000054087.48725.d9. Pharmacogenetics. 2003. PMID: 12724617

6

The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.

Białecka M, Droździk M, Kłodowska-Duda G, Honczarenko K, Gawrońska-Szklarz B, Opala G, Stankiewicz J. Białecka M, et al. Acta Neurol Scand. 2004 Oct;110(4):260-6. doi: 10.1111/j.1600-0404.2004.00315.x. Acta Neurol Scand. 2004. PMID: 15355491

7

Analysis of MDR1 haplotypes in Parkinson's disease in a white population.

Tan EK, Drozdzik M, Bialecka M, Honczarenko K, Klodowska-Duda G, Teo YY, Tang K, Wong LP, Chong SS, Tan C, Yew K, Zhao Y, Lee CG. Tan EK, et al. Among authors: bialecka m. Neurosci Lett. 2004 Dec 6;372(3):240-4. doi: 10.1016/j.neulet.2004.09.046. Neurosci Lett. 2004. PMID: 15542248

8

Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.

Białecka M, Droździk M, Honczarenko K, Gawrońska-Szklarz B, Stankiewicz J, Dabrowska E, Kubisiak M, Kłodowska-Duda G, Opala G. Białecka M, et al. Eur Neurol. 2005;53(2):68-73. doi: 10.1159/000084302. Epub 2005 Mar 7. Eur Neurol. 2005. PMID: 15753616

9

Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients.

Kurzawski M, Droździk M, Suchy J, Kurzawski G, Białecka M, Górnik W, Lubiński J. Kurzawski M, et al. Among authors: bialecka m. Eur J Clin Pharmacol. 2005 Jul;61(5-6):389-94. doi: 10.1007/s00228-005-0926-5. Epub 2005 May 24. Eur J Clin Pharmacol. 2005. PMID: 15912392

10

Analysis of LRRK 2 G 2019 S and I 2020 T mutations in Parkinson's disease.

Bialecka M, Hui S, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M. Bialecka M, et al. Neurosci Lett. 2005 Dec 16;390(1):1-3. doi: 10.1016/j.neulet.2005.07.045. Neurosci Lett. 2005. PMID: 16115731 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page